Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I

Abstract

rhDNase was ineffective and potentially harmful in this group of adult outpatients in stable condition with idiopathic bronchiectasis. This contrasts with previously published results that demonstrated efficacy of rhDNase in patients with cystic fibrosis bronchiectasis.